Genetic interplay between human longevity and metabolic pathways:a large-scale eQTL study by Häsler, Robert et al.
Syddansk Universitet
Genetic interplay between human longevity and metabolic pathways
Häsler, Robert; Venkatesh, Geetha; Tan, Qihua; Flachsbart, Friederike; Sinha, Anupam;
Rosenstiel, Philip; Lieb, Wolfgang; Schreiber, Stefan; Christensen, Kaare; Christiansen, Lene;
Nebel, Almut
Published in:
Aging Cell
DOI:
10.1111/acel.12598
Publication date:
2017
Document version
Publisher's PDF, also known as Version of record
Document license
CC BY
Citation for pulished version (APA):
Häsler, R., Venkatesh, G., Tan, Q., Flachsbart, F., Sinha, A., Rosenstiel, P., ... Nebel, A. (2017). Genetic
interplay between human longevity and metabolic pathways: a large-scale eQTL study. Aging Cell, 16(4),
716–725. DOI: 10.1111/acel.12598
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. aug.. 2017
Genetic interplay between human longevity and metabolic
pathways — a large-scale eQTL study
Robert H€asler,1,† Geetha Venkatesh,1,† Qihua Tan,2,3
Friederike Flachsbart,1 Anupam Sinha,1 Philip Rosenstiel,1
Wolfgang Lieb,4 Stefan Schreiber,1 Kaare Christensen,2,3,5
Lene Christiansen2 and Almut Nebel1
1Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany
2The Danish Twin Registry, Unit of Epidemiology, Biostatistics and
Biodemography, University of Southern Denmark, 5000 Odense, Denmark
3Department of Clinical Genetics, Odense University Hospital, 5000 Odense,
Denmark
4Institute of Epidemiology, Kiel University, 24105 Kiel, Germany
5Department of Clinical Biochemistry and Pharmacology, Odense University
Hospital, 5000 Odense, Denmark
Summary
Human longevity is a complex phenotype influenced by genetic
and environmental components. Unraveling the contribution of
genetic vs. nongenetic factors to longevity is a challenging task.
Here, we conducted a large-scale RNA-sequencing-based expres-
sion quantitative trait loci study (eQTL) with subsequent heri-
tability analysis. The investigation was performed on blood
samples from 244 individuals from Germany and Denmark,
representing various age groups including long-lived subjects
up to the age of 104 years. Our eQTL-based approach revealed
for the first time that human longevity is associated with a
depletion of metabolic pathways in a genotype-dependent and
independent manner. Further analyses indicated that 20% of the
differentially expressed genes are influenced by genetic variants
in cis. The subsequent study of twins showed that the transcrip-
tional activity of a third of the differentially regulated genes is
heritable. These findings suggest that longevity-associated bio-
logical processes such as altered metabolism are, to a certain
extent, also the driving force of longevity rather than just a
consequence of old age.
Key words: functional genomics; human; longevity; RNA-
sequencing; transcriptome.
Introduction
Human longevity is likely to be influenced by multiple genetic and
environmental factors as well as by chance (Martin et al., 2007). In
contrast to aging, which is a continuous process occurring in all
individuals, longevity is achieved only by a very small proportion of a
birth cohort. The genetic component to this rare phenotype has been
estimated at ~40% in long-lived individuals (LLI) who survive beyond
85 years (Murabito et al., 2012). Interestingly, many of the elderly who
attain such an extreme age also tend to be healthier for a longer period
of their overall lifetime than their peers who died decades earlier. They
achieve this extension of ‘healthspan’ by postponing the onset of major
age-related diseases and the beginning of functional decline (Andersen
et al., 2012). In addition, LLI often show beneficial profiles for some
metabolic parameters such as lipid and lipoprotein particle profiles
(Barzilai et al., 2003). On the genetic level, nonagenarians and
centenarians have been hypothesized to harbor specific alleles with
protective effects, so-called longevity variants, that may buffer or
counteract the numerous disease variants they carry (Bergman et al.,
2007; Beekman et al., 2010; Sebastiani et al., 2012). However, so far,
variation in only three loci, the APOE gene (Sch€achter et al., 1994; Rea
et al., 2015), the FOXO3A gene in the insulin-IGF1 pathway (Willcox
et al., 2008; Flachsbart et al., 2009; Soerensen et al., 2010), and a
region of unknown function on chromosome 5q33.3 (Deelen et al.,
2014), has been reported to influence survival beyond 90 years of age
in various populations. Many more genes are assumed to play a role in
human longevity, but they have remained undetected as yet despite
large-scale genome-wide efforts (Deelen et al., 2011, 2014; Nebel
et al., 2011; Beekman et al., 2013). As the genetic approaches have
thus far provided only limited information about the determinants and
molecular mechanisms underlying longevity, several studies have
focused on the molecular functional aspects of the phenotype by
analyzing the miRNA, epigenome, and transcriptome profiles of LLI
(Rodwell et al., 2004; Bollati et al., 2009; Harries et al., 2011;
ElSharawy et al., 2012; Passtoors et al., 2012). Yet many other studies
focused primarily on aging mechanisms rather than on longevity (Van
den Akker et al., 2014; Peters et al., 2015). The transcriptome of an
individual reflects the influence of both genetic variation and the
environment. A majority of transcriptome studies in longevity research
use a cross-sectional design (Rodwell et al., 2004; Harries et al., 2011;
Passtoors et al., 2012), in which data of LLI are compared with that of
younger participants who were born generations later. However, such a
setup is not suitable to distinguish between the changes in gene
expression that predispose to longevity and those that result from it
(Deelen et al., 2013). To partly overcome this limitation, we performed
in this study RNA-sequencing-based transcriptome profiling in blood
samples of 244 LLI and younger controls and subsequently employed an
expression quantitative trait loci (eQTL) analysis to investigate the
association between mRNA expression levels and single-nucleotide
polymorphisms (SNPs). As the SNPs involved in the eQTLs are consti-
tutional, they cannot be a consequence of longevity but represent one
of its underlying factors. Taken together, integrating genotype infor-
mation with high-resolution transcriptome data from this sample does
not only help elucidate functional mechanisms associated with long-
evity, but also provides for the first time the opportunity to assess the
genetic contribution to it.
Results
Differential gene expression between LLI and CI
The transcriptome analysis of 55 LLI and 73 CI (CI: control individuals,
German samples) identified 19 483 of 24 934 genes analyzed as
expressed in blood. Of these, 6214 were significantly differentially
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expressed (Benjamini-Hochberg corrected P-value ≤ 0.001; false discov-
ery rate FDR ≤ 0.1%) between LLI and CI including 3525 downregulated
and 2689 upregulated genes in LLI (Fig. 1, Table S1, Supporting
information, Appendix S1: Supplemental raw data, Supporting informa-
tion). Of those 6214 differentially expressed genes, 139 exhibited a high
correlation (r ≥ 0.8) with individual blood cell types (Palmer et al., 2006)
and were excluded from further analysis to control for altered cell
compositions due to age. Subjecting the remaining 6075 differentially
expressed genes to a gene ontology analysis resulted in 107 significant
biological processes. We found that eight of the ten most significantly
enriched or depleted biological processes were functionally linked to
metabolism, which is very unlikely to have occurred by chance
(P = 3.51 9 105; Fischer’s exact test). In addition, a larger number of
downregulated genes than expected by chance were associated with
these eight metabolic processes, which represents the most prominent
finding of the study. Most gene ontology categories were relatively
broad, for example, such as cellular macromolecule metabolic process,
nucleobase-containing compound metabolic process, heterocycle meta-
bolic process, or cellular aromatic compound metabolic process
(Table S2, Supporting information); however, upon closer inspection,
many of them seemed to point to nucleotide metabolism. Modulation
was also found in processes functionally linked to defense as well as to
cell and tissue regeneration, yet to a much lesser extent than in
metabolism (Fig. 2).
Comparing the P-values of differentially expressed genes with the
findings from five previous aging transcriptomics studies yielded Spear-
man rank correlation coefficients from 0.44 to 0.72. The overlap in the
direction of the fold change of each gene ranged from 65% to 100%
per gene (Table 2, Fig. S1, Supporting information). One specific gene,
namely LRRN3 (Leucine Rich Repeat Neuronal 3), was identified to be the
most significantly regulated gene by all studies including the present
one. LRRN3 was consistently found to be downregulated in older and/or
LLI.
eQTL and genotype–age (G3A) interaction analysis of the
differentially expressed genes
After quality control, 636 904 SNPs were used for the eQTL analysis in
the German sample. The cis-eQTL analysis identified 8757 statistically
significant cis-eQTLs associated with 1200 differentially expressed genes
(Fig. 3, Table S3, Supporting information). A subsequent G9A analysis
showed that 599 of these 1200 genes displayed an additional G9A
interaction (Table S4, Supporting information). An exemplary gene
exhibiting G9A interaction is shown in Fig. 3A and an example for a
gene with no GxA and no significant eQTL finding is shown in Fig. 3B.
The analysis of the frequency of the variants revealed that the majority
(25th to 50th percentile) of significant eQTL signals are found in 20–50%
of all individuals (Fig. 3C).
Integrating the identified biological processes with the transcriptome
and genotype data results in a complex hierarchical organization. To
illustrate this architecture, the complexity was reduced by including only
biological processes that contain 150 or more eQTL genes. We found
that 5119 variants influence 722 genes (eQTLs), further contributing to
40 biological processes that can be grouped into four major biological
categories, all of them affecting the longevity phenotype (Fig. 4).
Finally, comparing our eQTL findings with previously published
genetic variants associated with age-related diseases (GWAS catalog),
we did not observe an enrichment of these variants in our set of
identified eQTLs, keeping in mind that our experimental setup may not
be suitable to capture the enormous genetic variability of this trait.
Technical validation of selected differentially expressed
genes
We replicated our results from the differential expression analysis by
measuring the expression levels of 80 candidates (selected based on fold
change, significance of differential expression, and eQTL P-value,
Table S6, Supporting information) employing RT-qPCR in the German
samples (53 LLI and 70 CI; five samples were excluded due to lack of
RNA). Of the 80 genes, 74 were detectable, of which 50 were
significantly differentially expressed between LLI and CI. Moreover, these
50 genes were regulated in the same direction as in the transcriptome
sequencing data. A permutation analysis revealed that by chance, one
would have expected 0.042 of the 80 genes to be differentially
expressed; therefore, finding 50 differentially expressed genes
corresponds to a high validation rate, as reflected by a low probability
of detecting 50 genes by chance (Fisher’s exact test P-value=
7.57 9 1017).
Biological validation of differentially expressed genes and
cis-eQTLs
The 6075 differentially expressed genes in Germans were subjected to
further validation in the Danish samples (34 older individuals [83–
92 years], 34 younger individuals [58–60 years]). Of these genes, 5183
were regulated in the same direction as in the German dataset, with
1661 of those showed a Benjamini-Hochberg corrected P-value ≤ 0.05
and a FDR ≤ 5%. This concordance is significantly higher than expected
by chance (Fisher’s exact test, expected overlap vs. observed overlap; P-
value = 2.4 9 1013). A gene ontology analysis of these 1661 genes
found that nine of the 25 most significant biological processes were
functionally linked to metabolism, which is in concordance with the
findings in the German samples.
We further correlated the transcriptome and genotype data from the
68 Danish samples to validate the cis-eQTLs found in the German
dataset. Of the 1200 genes, which exhibited a significant association
with cis-variants in the German sample, 374 genes showed significant cis
association in the Danish dataset as well. In total, we found 3332
statistically significant cis-eQTLs associated with these 374 genes, of
which 2017 were unique to the Danish dataset.
Heritability estimation of gene expression
Of the 24 934 genes described in the annotation file (hg19), 15 640
were expressed in more than 95% of the blood samples of monozygotic
(MZ) and dizygotic (DZ) twins from Denmark (Appendix S2, Supporting
information, raw FPKM-values for all detected genes: Supplemental raw
data, Danish samples). Of these, 3029 genes are controlled by a heritable
component, which ranges from approximately 30% to 99% (Table S5,
Supporting information). Combining this with the above-mentioned
eQTL results (German dataset), an overlap of 334 genes was found:
These genes were differentially expressed and associated with a genetic
variant in cis, while at the same time also exhibited heritable transcrip-
tional activity. By chance, one would have expected 182 genes to
overlap. The observed 1.8-fold enrichment was highly significant
(Fisher’s exact test, P = 1.90 9 1036).
Discussion
Understanding the nature of human longevity is a challenging task, as
this heterogeneous phenotype is influenced by both genetic and
Genomics of metabolic pathways in human longevity, R. H€asler et al. 717
ª 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Fig. 1 Genes differentially expressed with chronological age. (A) Hierarchical clustering of the top 50 genes, exhibiting the strongest correlation with chronological age.
Each column represents an individual, while each row represents a transcript that is labeled with the corresponding gene symbol. Column dendrograms display similarities
between samples and row dendrograms display transcript similarities. The orange column on the far right, which classifies genes by their involvement in metabolism,
illustrates the downregulation of metabolism-associated transcripts with age. For the top ten mRNA transcripts with positive or negative correlation with chronological age,
please refer to Fig. S4 (Supporting information). (B) Differentially expressed genes identified vs. individuals included in the study setup, exemplified for the German cohort
(max. n = 128 individuals). Randomly selected individuals were added to the analysis to estimate the resulting number of significantly differentially expressed genes (adjusted
P-value ≤ 0.001). For better visualization, a curve fit was added. In addition, three previously published genes (LRRN4, CD248, and ABLIM1) and the strongest pathway signal
(GO-term) are displayed with their significances (log10P-value).
Genomics of metabolic pathways in human longevity, R. H€asler et al.718
ª 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
environmental components. Conservative genetic approaches in long-
evity research have resulted so far in only very few associations that were
consistently replicated in various samples (Sch€achter et al., 1994; Willcox
et al., 2008; Flachsbart et al., 2009; Nebel et al., 2011; Deelen et al.,
2014). The majority of genetic findings could not be verified indepen-
dently (Christensen et al., 2006), suggesting that a large number of
different variants may lead to the same phenotypic outcome and
rendering it difficult to identify susceptibility factors shared by several
populations. To overcome the limitation of a purely genetic study design,
some investigations focused on the transcriptome of LLI that reflects
both environmental and genetic influences. In the present study, this
approach was expanded by integrating, for the first time in longevity
research, RNA-sequencing data from blood samples of 244 LLI and
younger controls with genotype information from the same individuals,
followed by a heritability analysis in twins. Employing this setup, the
study’s objective was to identify biological processes associated with
longevity and to assess the genetic and nongenetic contribution to
those.
In contrast to previous studies, a substantial higher number of genes
were observed to be differentially expressed. This observation may be
mostly attributed to the high dynamic range of the applied RNA-
sequencing technology (Zhao et al., 2014). The top candidates identified
here (LRRN3, P = 5.40 9 1020; ABLIM1, P = 2.50 9 1011; CD248,
P = 1.50 9 1023, see Table S1, Supporting information) were in
agreement with previously published findings (Hong et al., 2008; Harries
et al., 2011; Passtoors et al., 2012; Van den Akker et al., 2014; Peters
et al., 2015), which confirms the validity of our setup (Table 2, Fig. S1,
Supporting information). The overlap between previous findings with the
results presented here is illustrated in Fig. S2 (Supporting information).
The top three genes, prominently identified by all previous studies, are
shown with their cross-sectional mRNA expression in Fig. S3 (Supporting
information, ABLIM1, CD248, LRRN3). An earlier blood-based eQTL
meta-study (Westra et al., 2013), despite its large sample size, is not
suitable to display longevity effects, as the samples were composed of
continuous age-ranges, excluding extremely long-lived individuals.
Consequently, the previously observed effects reflect mostly aging,
while the results presented here are likely to be a combination of both
Fig. 2 Biological processes in longevity are controlled by genetic and nongenetic factors. For better readability, only processes with at least 150 genes are
displayed. A strong depletion of processes associated with metabolism (orange) is the most prominent finding, while the effects on defense (blue) and cell
and tissue regeneration (green) are less dominant. Processes that are not part of these three categories are displayed in grey. The contribution of
age–genotype interaction (dark shading, inner circle) represents a part of the genetic contribution (cis-eQTL, middle circle), while the remaining effects
(environment, epigenetics etc.) are labeled nongenetic contribution (light shading, outer circle). The y-axis is arranged by process category, while the x-axis
illustrates the degree of enrichment or depletion of the individual processes (log10P). The ten depleted metabolism-associated processes are (orange, top
left section, from left to right): cellular macromolecule metabolic process, regulation of metabolic process, macromolecule metabolic process, nucleobase-
containing compound metabolic process, cellular aromatic compound metabolic process, heterocycle metabolic process, organic cyclic compound metabolic
process, cellular nitrogen compound metabolic process, protein metabolic process, and phosphorus metabolic process.
Table 1 Overview of study participants
Number of
individuals
Age range
(years)
Gender
(f/m) Country
Long-lived
individuals (LLI)
55 90–104 40/15 GER
Control individuals (CI) 73 20–55 45/28 GER
Long-lived twins (LLT) 48 (28 DZ, 20 MZ) 83–92 32/16 DK
Control twins (CT) 48 (24 DZ, 24 MZ) 58–60 32/16 DK
Unrelated LLI 10 83–92 8/2 DK
Unrelated CI 10 58–60 4/6 DK
Country: Germany (GER), Denmark (DK).
DZ: dizygotic, MZ: monozygotic.
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aging and longevity. To critically assess the power of our analysis, we
conducted a permutation-based power estimation, illustrating that the
study setup selected is appropriate to deliver significant results and
therefore appropriate to support our conclusions (Fig. 1B). Similarly, the
successful technical validation of selected genes by quantitative real-time
PCR documents that RNA-sequencing is a precise method for identifying
differentially expressed genes as indicated by the low probability of our
results being validated by chance (P-value = 7.57 9 1017). In the same
context, the biological validation of findings from the German study
population in Danes showed a high concordance (P-value of this overlap
not occurring by chance: 2.4 9 1013).
Quantitative data from whole blood are known to be influenced by
altered cell compositions, yet focusing on only one selected cell
population in blood might not be sufficient to create a broad picture
of longevity-associated transcriptome patterns, as it is unclear which cell
type contributes dominantly to these patterns. Moreover, whole blood
has been shown to reflect the age-related molecular changes seen in
other tissues quite well (Passtoors et al., 2008). The presented approach,
that is, omitting all genes that show a high correlation with specific
blood cell types (Palmer et al., 2006), introduces a degree of robustness,
because it removes all signals which are likely to fluctuate as a result of
age-related cell composition changes.
Further analysis revealed that about 20% of the identified
differentially expressed genes were influenced by cis-variants (Table
S3, Supporting information), while about half of those exhibited an
additional genotype–age interaction: The same genotype exerts a
different effect at different ages (Table S4, Supporting information,
exemplified in Fig. 3A). Interestingly, we could not find an enrichment
of genetic variants associated with age-related phenotypes such as
Parkinson’s disease, type II diabetes, or others in our group of
cis-variants.
Monitoring rare or private variants in longevity is not possible with the
setup presented here. Consequently, our approach can focus only on
shared effects: The majority of eQTL signals occur in 20 to 50% of all
individuals (Fig. 3C). This is in concordance with a previous large-scale
eQTL study by the GEUVADIS consortium, employing 462 transcriptomes
with corresponding genomes, where the majority of eQTLs identified
were shared as well (Lappalainen et al., 2013).
As each gene can potentially interact with all the detected variants
(730 525 SNPs) in trans, we categorized all non-cis interactions as
nongenetic: In any given experimental setup, trans-interactions are
almost undetectable, despite their presence and potential relevance. We
are aware that categorizing the remaining 80% as nongenetic is likely to
be an overestimation due to the contribution of trans-regulatory effects.
Keeping this in mind, the conclusion that 80% of the genes were not
under cis-regulation still supports the notion that longevity is influenced
to a large extent by nongenetic factors (Talens et al., 2012).
Fig. 3 Age-associated transcripts and influence of genetic variation. One under genetic control (A, ETV7) and one independent of genetic control (B,
SARNP), while ETV7 shows an additional age–genotype interaction. Frequencies of eQTL variants (C) are shown color-coded with the corresponding P-value
(-log10P).
Fig. 4 Hierarchical organization of eQTL effects on longevity. Four
different layers are represented with their hierarchical connections: 5119
variants influencing the longevity-associated mRNA expression of 722
genes, contributing to 40 biological processes, which are grouped in four
categories. The graph is based on biological processes that contain at least
150 genes significantly associated with longevity (corresponding to Fig. 2).
For better readability, the number of displayed connections between two
hierarchical levels was limited to a maximum of 200. The y-axis
corresponds to the hierarchical level, while the x-axis represents the
genomic location of genes and variants.
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The genetic influence observed here was further emphasized by the
subsequent heritability analysis revealing that only 19% of all genes are
influenced by detectable heritability (Table S5, Supporting information).
Moreover, the variation in those heritable genes was explained by
heritability in a range from 30% to 99%. This highlights that most genes
with a heritable component are under additional control of nongenetic
factors, while the majority of genes show no heritable influence.
Consequently, it appears there is no biological process that is indepen-
dent of a nongenetic contribution.
Interestingly, about one-third of the genes that were influenced by
cis-variants also displayed a significant heritable component in an
independent set of samples, which is substantially more than expected
by chance (enrichment P-value P = 1.90 9 1034). In contrast to that,
several genetic variants might require additional environmental or
genetic effects to display a functional impact on mRNA expression,
explaining why a large number of genes that were influenced by cis-
variants did not show a heritable component. Finally, our observations
on the heritability on the molecular level are in concordance with
previous findings on the phenotype level of familial aggregation of
longevity as reviewed in Murabito et al., 2012.
As a primary result of the subsequent gene ontology analysis, we
found 107 biological processes associated with longevity, most of which
were assigned to one of the three categories: metabolism, tissue and cell
regeneration as well as immune system and defense. Within this, the
most prominent finding is the significant depletion of processes
functionally linked with metabolism (Fig. 2), which dominates by
number of genes per process (median: 1103) as well as by significance
(min. P = 3.5 9 1024). Keeping the limitations of pathway-analysis
approaches in mind, the unusually large number of genes associated
with the individual metabolic process (1085–1555) further increases our
confidence in this finding. Here, the large number of metabolism-
associated processes identified might indicate a key role of this process
category in longevity. Modulations in cell and tissue regeneration and in
defense processes were significant as well, yet less dominant as the
number of genes contributing to these observations was substantially
lower. The depletion of metabolic processes resulted mostly from a
downregulation of metabolism-associated genes in both the German
and Danish LLI. The downregulation may point to an existing reduced
(resting) metabolic rate that in turn has been linked with increased
lifespan in humans (Ruggiero et al., 2008; Rozing et al., 2010).
Unfortunately, no metabolic rate data were available for our study
participants.
Our results support the hypothesis that a subgroup of individuals,
exhibiting patterns of reduced metabolism (whether due to genetic and/
or environmental factors), is more likely to reach old age in a healthy
state. An interesting question that arises in this context is if these
patterns in LLI are a consistent feature throughout their lives or are they
restricted only to advanced age? The approach applied here using cross-
sectional data does not allow us to address this issue. If the former was
the case, the younger individuals that cluster with the LLI based on
downregulation of metabolism-associated genes (highlighted in Fig. 1A)
might represent good candidates for people living up to their nineties
and beyond.
It is not unlikely that the downregulation of metabolism-associated
genes illustrates the lifestyle of the LLI when compared to younger
controls, attributed to moderate food intake and reduced physical
activity (Von Wurmb-Schwark et al., 2010). In this context, it is
important to mention the hypothesis of longevity being linked to caloric
restriction, which is supported by several prominent observations: For
example in Okinawans, caloric restriction and traditional functional food
were suggested to play a role in extended lifespan (Willcox & Willcox,
2014). Similarly, caloric restriction has been proposed to have beneficial
effects for age-related outcomes in the CALERIE cohort (Ravussin et al.,
2015). While our findings seem to further support this hypothesis, our
data do not allow creating a direct link to caloric restriction, as we have
demonstrated a depletion of metabolic processes without measuring
metabolic rates or caloric intake.
Considering that the majority (~80%) of the observed depletion of
metabolic processes is independent of genetics, one could assume that
this is indeed the result of longevity. In contrast to this, the genetic
contribution (~20%) to this depletion allows a second implication:
Individuals with a given genetic setup will have an altered metabolic
pattern, resulting in a higher probability of reaching old age. Therefore,
our eQTL findings support the concept that longevity is not only a
consequence of environmental factors, but also driven by genetics.
Moreover, the complexity of the genetic contribution is further increased
by the fact that some variants have different impacts at different ages, as
demonstrated by our findings on genotype–age interaction (Fig. 3).
It is important to note that the observed depletion of metabolic
processes has limited predictive value for other samples: The cross-
Table 2 Overlap with previous studies in aging/longevity transcriptomics
Hong Harries Passtoors Akker Peters
Study year 2008 2011 2012 2014 2015
Overlap 100% 100% 98% 65% 73%
Overlap P-value 3.2 9 1014 3.8 9 1051 6.9 9 10154 <1.0 9 10300† <1.0 9 10300†
SRCC 0.73 0.62 0.60 0.44 0.61
Shared genes in top 10 FCGBP
LRRN3‡
NRCAM
PDGFRB
ABLIM1
CCR7
CD248
FAM102A
LRRN3‡
NELL2
ABLIM1
CAMK4
CD248
LRRN3‡
NOG
LRRN3‡
NELL2
ABLIM1
CD248
FAM102A
LRRN3‡
NELL2
The following publications were used to generate this table: Hong (Hong et al., 2008), Harries (Harries et al., 2011), Passtoors (Passtoors et al., 2012), Akker (Van den Akker
et al., 2014), and Peters (Peters et al., 2015). The overlap was calculated based on how many identified genes were significantly regulated and concordant in their regulation
direction. Spearman rank correlation coefficient (SRCC) was calculated using all genes identified in the corresponding study. Shared genes in top 10 describes which genes
were found in both studies to be among the top 10 most significantly regulated transcripts, ranked by false discovery rate (Van den Akker) or by P-value (all others).
†Fisher’s exact test P-value could not be calculated (P < 1.0 9 10300).
‡LRRN3 (Leucine Rich Repeat Neuronal 3) was identified as the most significantly regulated gene by all studies including the present one.
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sectional study design employed here may overestimate this depletion by
reflecting differences between birth cohorts, yet the correlation between
altered expression and increasing chronological age (Fig. 3A, Fig. S4,
Supporting information) supports a noncohort-specific effect. This is
facilitated by the large age windows covered by our cohorts (see also
Fig. S4, Supporting information); our study setup neither allows nor aims
at monitoring aging effects but instead is designed to identify charac-
teristics of long-lived individuals. In contrast to that, an alternative
longitudinal setup suffers similar limitations as findings in longitudinal
studies potentially have validity only for the birth cohort investigated.
Keeping the limitations of the cross-sectional study design in mind, the
integration of stable genomic data with dynamic transcriptome data
from different age windows allows us to illustrate the functional
consequences of genetic variations. As the SNPs observed in the eQTLs
cannot be the result of longevity, this approach offers the unique
opportunity to identify potentially causative factors contributing to the
phenotype.
Finally, our results might also partially explain why replication of
genetic longevity associations is a challenging task. We observed a
hierarchical structure, where a large number of heterogeneous heritable
and nonheritable, genetic and nongenetic components potentially lead
to altered pathway patterns, which finally may result in longevity. The
heterogeneity of factors contributing to the same phenotype, as
illustrated in Fig. 4, might explain why some genetic associations appear
to be valid only in a specific population. Moreover, the independent
cohort from Denmark we employed to biologically validate our findings
in German individuals displayed the same modulation in metabolic
pathways, yet the genes and variants of origin did only partially overlap
between Danes and Germans. This provides further support for the
concept of a hierarchical structure, where different genetic variations
lead to the same phenotype.
Taken together, our systems biology-based analysis on unique
longevity samples illustrates, for the first time, how human longevity is
associated with a depletion of metabolic pathways in a genotype-
dependent and independent manner. At the same time, our eQTL
findings indicate that those processes are, to some extent, also a driving
force of longevity rather than only a consequence of old age.
Experimental procedures
Study populations
This study included a total of 244 whole blood samples from LLI and
control individuals (CI) (Table 1). The samples of the German subjects
were collected with the support of the biobank PopGen, as previously
described (Nebel et al., 2005). The Danish individuals were recruited
from two population-based and nationwide twin surveys conducted at
the Danish Twin Registry: the Longitudinal Study of Middle-aged Danish
Twins and the Longitudinal Study of Aging Danish Twins (Skytthe et al.,
2013) (Table 1). All participants signed a written informed consent.
Approval for the study was received from the Ethics Committees of Kiel
University and the Regional Scientific Ethical Committees for Southern
Denmark.
Sample processing
Total RNA was extracted for all 244 individuals from frozen blood
samples using the PAXgene Blood miRNA kit (Qiagen) according to the
manufacturer’s protocol. Paired-end libraries were prepared with the
Illumina TruSeq RNA Sample Preparation Kit, multiplexed with four
samples per lane and sequenced on an Illumina HiSeq 2000.
For the German study population, DNA was extracted from EDTA
whole blood using the Invisorb Blood Giga Kit following the manufac-
turer’s instructions. DNA samples from all German individuals (55 LLI and
73 CI) were subjected to genotyping employing the HumanOmniExpress
BeadChip (Illumina) that monitors 730 525 SNPs. For the Danish
population, DNA was extracted by a salting-out procedure either
performed manually or with the AutoPure LS instrument (Qiagen). One
individual from each of the 22 MZ pairs (LLT = 10 pairs and CT = 12
pairs) as well as 52 DZ twin individuals (LLT = 14 pairs and CT = 12 pairs)
and 20 unrelated individuals (10 LLI and 10 CI) were selected for
genotyping.
Data analysis
The sequencing reads that failed the Illumina chastity filter (chastity
threshold = 0.6) were removed with the Illumina CASAVA-1.8 FASTQ
filter v0.1. Subsequent alignment to the UCSC Homo sapiens reference
genome (build hg19) was performed with TopHat v2.0.4 (Trapnell et al.,
2009). The aligned reads were assembled into transcripts and gene-level
abundance in terms of fragments per kilobase of exon per million
fragments mapped (FPKM) was estimated by Cufflinks v2.0.2 (Trapnell
et al., 2010). After quantile sample-to-sample normalization, the
FPKM estimates from the German samples were used to identify the
differentially expressed genes. Only genes with a log2 FPKM > 0 in more
than 5% of the samples were subjected to further analysis, while
differential expression was determined using a nonparametric Wilcoxon
rank sum test. Genes with a corrected P-value ≤ 0.001 (employing
Benjamini and Hochberg’s correction) and a false discovery rate (FDR)
≤ 0.1% based on a Westfall and Young permutation of the fold changes
were considered to be significantly differentially expressed. Differentially
expressed genes that highly correlated (r ≥ 0.8) with blood cell counts
(Palmer et al., 2006) were omitted from further analysis.
Gene expression data from the Danish twins were used to estimate
the heritability of transcriptional activity. Only genes that were expressed
(i.e., log2 FPKM > 0) in more than 95% of the samples were subjected
to heritability estimation that assessed additive genetic effects. An ACE
model (A: additive genetics, C: common environment, E: unique
environment) was fitted using biometric modeling (R package mets
v0.1-13) and was allowed to compete with the parsimonious nested
models, namely AE, CE, and E. The best fitting model was chosen based
on the Akaike information criterion (AIC) (Akaike, 1974) for non-nested
models and the likelihood ratio test for nested models. The final
heritability estimate was obtained from the best fitting model.
Genes that were differentially expressed between LLI and CI (German
dataset) were subjected to cis-eQTL analysis. Only variants located within
a 1-Mb up- and downstream of the starting and end points of the gene
were included in the analysis. SNPs with minor allele frequencies below
1%, call rate below 95%, and Hardy–Weinberg equilibrium testing P-
value ≤ 0.0001 were filtered out. The eQTL analysis for the German
samples was performed with PLINK v1.07 (Purcell et al., 2007). The
obtained cis-eQTLs were adjusted using a Benjamini and Hochberg
correction for multiple testing at an a level of 5%. Furthermore, the SNPs
that exhibited significant association with gene expression (cis-eQTLs)
were compared with genetic variants from GWAS catalog (https://
www.ebi.ac.uk/gwas/) to examine whether there is an enrichment of
variants associated with age-related diseases in our identified eQTLs. To
assess the frequency of variances per gene, all significant eQTL findings
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were binned according to their occurrence in the German study
population.
To assess the genotype–age interaction (G9A), only differentially
expressed genes with at least one significant cis-eQTL were considered.
The G9A interaction for each gene and the most significant cis-eQTL
were investigated by employing a linear mixed model as described
previously (Glass et al., 2013).
The overlap with previous studies (Hong et al., 2008; Harries et al.,
2011) was assessed by transforming the observed P-values to log
(P,100), multiplied with the sign of the fold change, to properly reflect
the direction of regulation. For one study (Harries et al., 2011), only the
false discovery rate data were available which was used equivalently.
Subsequently, the transformed P-values of the genes that were found in
both our study and the previous one were subjected to a correlation
analysis using the Spearman rank correlation. The expected overlap
between studies was based on the number of identified genes in each
study, assuming a genomewide approach. The overlap P-value was
calculated employing a Fisher’s exact test comparing observed vs.
expected overlap.
Functional analysis: gene ontology
Gene ontology analysis was performed by associating genes of interest
to gene ontology terms (retrieved from http://www.geneontology.org),
followed by a two-sided Fisher’s exact test to determine significance of
enrichment or depletion. Finally, resulting P-values were adjusted
employing a Benjamini and Hochberg’s correction for multiple testing.
Technical validation of differential gene expression by
real-time PCR
Eighty candidate genes were selected based on the ranks of their fold
changes, P-values, and regulation of their expression by cis-eQTLs and
were subjected to validation in the German samples. Real-time PCR
(TaqMan) was performed according to the manufacturer’s instructions
(Applied Biosystems) on a 7900HT real-time PCR system. Gene expres-
sion levels were quantified relative to the median of three genes (RER1,
E2F4, BFAR) that showed minimum variation in the expression levels
across the samples. Differences between LLI and CI were determined
with the Wilcoxon rank sum test and the P-values were corrected using
Benjamini and Hochberg’s method.
Biological validation of differential gene expression and
cis-eQTLs using Danish samples
In total, 68 individuals were included in the validation set (10 unrelated
LLI, 10 unrelated controls, and 48 individuals selected from 48 twin pairs:
22 MZ and 26 DZ – Table 1). The RNA-sequencing-based transcriptome
data from these 68 samples were analyzed as described above to identify
and validate the differentially expressed genes detected in the German
dataset. As the validation dataset was smaller than the German sample,
the genes with a corrected P-value ≤ 0.05 and a FDR ≤ 5% were
considered to be significantly differentially expressed. The genotype and
gene expression data were analyzed using PLINK.
Acknowledgments
First, we would like to thank all study participants in Germany and
Denmark for enabling us to conduct this study. In addition, we would
like to thank Ina Clefsen, Melanie Friskovec, Catharina von der Lancken,
Dorina Oelsner, Markus Schilhabel, Melanie Schlapkohl, Ilona Urbach,
and Tanja Wesse at the Institute of Clinical Molecular Biology for the
excellent technical assistance as well as Gunnar Jacobs for the
recruitment via PopGen.
Funding
The Danish Twin Registry is supported by grants from The National
Program for Research Infrastructure 2007 (09-063256) from the Danish
Agency for Science Technology and Innovation, the Velux Foundation,
and the US National Institute of Health (P01 AG08761). This study was
funded by INTERREG 4A Syddanmark-Schleswig-K.E.R.N., the Excellence
Cluster ‘Inflammation at Interfaces’ (DFG), the PopGen 2.0 network
(BMBF, 01EY1103), and by the German National Genome Research
Network (NGFN, BMBF).
Author contributions
RH participated in designing the study, supervising the analysis, and
writing the manuscript. GV carried out the analysis and contributed to
writing the manuscript. QT participated in the analysis and supervised
the analysis. FF participated in designing and coordinating the study. PR
participated in the sequencing analysis, coordinating the study, and
drafting the manuscript. WL contributed to the study design and the
analysis. SS, KC, LC, and AN participated in study design, coordination of
the study, and drafting and finalizing the manuscript.
Conflict of interest
All authors read and approved the final manuscript and declare no
conflict of interest.
References
Akaike H (1974) A new look at the statistical model identification. IEEE Trans.
Autom. Control 19, 716–723.
Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT (2012) Health span
approximates life span among many supercentenarians: compression of mor-
bidity at the approximate limit of life span. J. Gerontol. A. Biol. Sci. Med. Sci. 67,
395–405.
Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, Lipton R, Cheng S,
Shuldiner AR (2003) Unique lipoprotein phenotype and genotype associated
with exceptional longevity. JAMA. 290, 2030–2040.
Beekman M, Nederstigt C, Suchiman HED, Kremer D, van der Breggen R,
Lakenberg N, Alemayehu WG, de Craen AJM, Westendorp RGJ, Boomsma DI,
de Geus EJC, Houwing-Duistermaat JJ, Heijmans BT, Slagboom PE (2010)
Genome-wide association study (GWAS)-identified disease risk alleles do not
compromise human longevity. Proc. Natl. Acad. Sci. USA 107, 18046–18049.
Beekman M, Blanche H, Perola M, Hervonen A, Bezrukov V, Sikora E, Flachsbart
F, Christiansen L, De Craen AJM, Kirkwood TBL, Rea IM, Poulain M, Robine
JM, Valensin S, Stazi MA, Passarino G, Deiana L, Gonos ES, Paternoster L,
Sørensen TIA, Tan Q, Helmer Q, Van Den Akker EB, Deelen J, Martella F,
Cordell HJ, Ayers KL, Vaupel JW, T€ornwall O, Johnson TE, Schreiber S,
Lathrop M, Skytthe A, Westendorp RGJ, Christensen K, Gampe J, Nebel A,
Houwing-Duistermaat JJ, Slagboom PE, Franceschi C (2013) Genome-wide
linkage analysis for human longevity: genetics of healthy aging study. Aging
Cell 12, 184–193.
Bergman A, Atzmon G, Ye K, MacCarthy T, Barzilai N (2007) Buffering
mechanisms in aging: a systems approach toward uncovering the genetic
component of aging. PLoS Comput. Biol. 3, 1648–1656.
Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H, Sparrow D, Vokonas
P, Baccarelli A (2009) Decline in genomic DNA methylation through aging in a
cohort of elderly subjects. Mech. Ageing Dev. 130, 234–239.
Christensen K, Johnson TE, Vaupel JW (2006) The quest for genetic determinants
of human longevity: challenges and insights. Nat. Rev. Genet. 7, 436–448.
Genomics of metabolic pathways in human longevity, R. H€asler et al. 723
ª 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
Deelen J, Beekman M, Uh HW, Helmer Q, Kuningas M, Christiansen L, Kremer D,
van der Breggen R, Suchiman HED, Lakenberg N, van den Akker EB, Passtoors
WM, Tiemeier H, van Heemst D, de Craen AJ, Rivadeneira F, de Geus EJ, Perola
M, van der Ouderaa FJ, Gunn DA, Boomsma DI, Uitterlinden AG, Christensen K,
van Duijn CM, Heijmans BT, Houwing-Duistermaat JJ, Westendorp RGJ,
Slagboom PE (2011) Genome-wide association study identifies a single major
locus contributing to survival into old age; the APOE locus revisited. Aging Cell
10, 686–698.
Deelen J, Beekman M, Capri M, Franceschi C, Slagboom PE (2013) Identifying the
genomic determinants of aging and longevity in human population studies:
progress and challenges. BioEssays 35, 386–396.
Deelen J, Beekman M, Uh H-W, Broer L, Ayers KL, Tan Q, Kamatani Y, Bennet AM,
Tamm R, Trompet S, Guðbjartsson DF, Flachsbart F, Rose G, Viktorin A, Fischer
K, Nygaard M, Cordell HJ, Crocco P, van den Akker EB, B€ohringer S, Helmer Q,
Nelson CP, Saunders GI, Alver M, Andersen-Ranberg K, Breen ME, van der
Breggen R, Caliebe A, Capri M, Cevenini E, Collerton JC, Dato S, Davies K, Ford I,
Gampe J, Garagnani P, de Geus EJC, Harrow J, van Heemst D, Heijmans BT,
Heinsen F-A, Hottenga J-J, Hofman A, Jeune B, Jonsson PV, Lathrop M, Lechner
D, Martin-Ruiz C, McNerlan SE, Mihailov E, Montesanto A, Mooijaart SP,
Murphy A, Nohr EA, Paternoster L, Postmus I, Rivadeneira F, Ross OA, Salvioli S,
Sattar N, Schreiber S, Stefansson H, Stott DJ, Tiemeier H, Uitterlinden AG,
Westendorp RGJ, Willemsen G, Samani NJ, Galan P, Sørensen TIA, Boomsma DI,
Jukema JW, Rea IM, Passarino G, de Craen AJM, Christensen K, Nebel A,
Stefansson K, Metspalu A, Magnusson P, Blanche H, Christiansen L, Kirkwood
TBL, van Duijn CM, Franceschi C, Houwing-Duistermaat JJ, Slagboom PE (2014)
Genome-wide association meta-analysis of human longevity identifies a novel
locus conferring survival beyond 90 years of age. Hum. Mol. Genet. 23, 4420–
4432.
ElSharawy A, Keller A, Flachsbart F, Wendschlag A, Jacobs G, Kefer N, Brefort T,
Leidinger P, Backes C, Meese E, Schreiber S, Rosenstiel P, Franke A, Nebel A
(2012) Genome-wide miRNA signatures of human longevity. Aging Cell 11,
607–616.
Flachsbart F, Caliebe A, Kleindorp R, Blanche H, von Eller-Eberstein H, Nikolaus S,
Schreiber S, Nebel A (2009) Association of FOXO3A variation with human
longevity confirmed in German centenarians. Proc. Natl. Acad. Sci. USA 106,
2700–2705.
Glass D, Vi~nuela A, Davies MN, Ramasamy A, Parts L, Knowles D, Brown AA,
Hedman AK, Small KS, Buil A, Grundberg E, Nica AC, Meglio P, Nestle FO, Ryten
M, Durbin R, McCarthy MI, Deloukas P, Dermitzakis ET, Weale ME, Bataille V,
Spector TD (2013) Gene expression changes with age in skin, adipose tissue,
blood and brain. Genome Biol. 14, R75.
Harries LW, Hernandez D, Henley W, Wood AR, Holly AC, Bradley-Smith RM,
Yaghootkar H, Dutta A, Murray A, Frayling TM, Guralnik JM, Bandinelli S,
Singleton A, Ferrucci L, Melzer D (2011) Human aging is characterized by
focused changes in gene expression and deregulation of alternative splicing.
Aging Cell 10, 868–878.
Hong M-G, Myers AJ, Magnusson PKE, Prince JA (2008) Transcriptome-wide
assessment of human brain and lymphocyte senescence. PLoS ONE 3, e3024.
Lappalainen T, Sammeth M, Friedl€ander MR, ‘t Hoen PAC, Monlong J, Rivas MA,
Gonzalez-Porta M, Kurbatova N, Griebel T, Ferreira PG, Barann M, Wieland T,
Greger L, van Iterson M, Alml€of J, Ribeca P, Pulyakhina I, Esser D, Giger T,
Tikhonov A, Sultan M, Bertier G, MacArthur DG, Lek M, Lizano E, Buermans HPJ,
Padioleau I, Schwarzmayr T, Karlberg O, Ongen H, Kilpinen H, Beltran S, Gut M,
Kahlem K, Amstislavskiy V, Stegle O, Pirinen M, Montgomery SB, Donnelly P,
McCarthy MI, Flicek P, Strom TM, Geuvadis Consortium, Lehrach H, Schreiber S,
Sudbrak R, Carracedo A, Antonarakis SE, H€asler R, Syv€anen A-C, van Ommen G-
J, Brazma A, Meitinger T, Rosenstiel P, Guigo R, Gut IG, Estivill X, Dermitzakis ET
(2013) Transcriptome and genome sequencing uncovers functional variation in
humans. Nature 501, 506–511.
Martin GM, Bergman A, Barzilai N (2007) Genetic determinants of human health
span and life span: progress and new opportunities. PLoS Genet. 3, e125.
Murabito JM, Yuan R, Lunetta KL (2012) The search for longevity and healthy
aging genes: insights from epidemiological studies and samples of long-lived
individuals. J. Gerontol. A Biol. Sci. Med. Sci. 67, 470–479.
Nebel A, Croucher PJP, Stiegeler R, Nikolaus S, Krawczak M, Schreiber S (2005) No
association between microsomal triglyceride transfer protein (MTP) haplotype
and longevity in humans. Proc. Natl. Acad. Sci. USA 102, 7906–7909.
Nebel A, Kleindorp R, Caliebe A, Nothnagel M, Blanch H, Junge O, Wittig M,
Ellinghaus D, Flachsbart F, Wichmann HE, Meitinger T, Nikolaus S, Franke A,
Krawczak M, Lathrop M, Schreiber S (2011) A genome-wide association study
confirms APOE as the major gene influencing survival in long-lived individuals.
Mech. Ageing Dev. 132, 324–330.
Palmer C, Diehn M, Alizadeh A, Brown P (2006) Cell-type specific gene expression
profiles of leukocytes in human peripheral blood. BMC Genom. 7, 115.
Passtoors WM, Beekman M, Gunn D, Boer JM, Heijmans BT, Westendorp RGJ,
Zwaan BJ, Slagboom PE (2008) Genomic studies in ageing research: the need to
integrate genetic and gene expression approaches. J. Intern. Med. 263,
153–166.
Passtoors WM, Boer JM, Goeman JJ, van den Akker EB, Deelen J, Zwaan BJ,
Scarborough A, van der Breggen R, Vossen RHAM, Houwing-Duistermaat JJ, van
Ommen GJB, Westendorp RGJ, van Heemst D, de Craen AJM, White AJ, Gunn
DA, Beekman M, Slagboom PE (2012) Transcriptional profiling of human familial
longevity indicates a role for ASF1A and IL7R. PLoS ONE 7, e27759.
Peters MJ, Joehanes R, Pilling LC, Schurmann C, Conneely KN, Powell J,
Reinmaa E, Sutphin GL, Zhernakova A, Schramm K, Wilson YA, Kobes S,
Tukiainen T, NABEC/UKBEC Consortium, Ramos YF, G€oring HHH, Fornage M,
Liu Y, Gharib SA, Stranger BE, De Jager PL, Aviv A, Levy D, Murabito JM,
Munson PJ, Huan T, Hofman A, Uitterlinden AG, Rivadeneira F, van Rooij J,
Stolk L, Broer L, Verbiest MMPJ, Jhamai M, Arp P, Metspalu A, Tserel L,
Milani L, Samani NJ, Peterson P, Kasela S, Codd V, Peters A, Ward-Caviness
CK, Herder C, Waldenberger M, Roden M, Singmann P, Zeilinger S, Illig T,
Homuth G, Grabe H-J, V€olzke H, Steil L, Kocher T, Murray A, Melzer D,
Yaghootkar H, Bandinelli S, Moses EK, Kent JW, Curran JE, Johnson MP,
Williams-Blangero S, Westra H-J, McRae AF, Smith JA, Kardia SLR, Hovatta I,
Perola M, Ripatti S, Salomaa V, Henders AK, Martin NG, Smith AK, Mehta D,
Binder EB, Nylocks KM, Kennedy EM, Klengel T, Ding J, Suchy-Dicey AM,
Enquobahrie DA, Brody J, Rotter JI, Chen Y-DI, Houwing-Duistermaat J,
Kloppenburg M, Slagboom PE, Helmer Q, den Hollander W, Bean S, Raj T,
Bakhshi N, Wang QP, Oyston LJ, Psaty BM, Tracy RP, Montgomery GW,
Turner ST, Blangero J, Meulenbelt I, Ressler KJ, Yang J, Franke L, Kettunen J,
Visscher PM, Neely GG, Korstanje R, Hanson RL, Prokisch H, Ferrucci L, Esko
T, Teumer A, van Meurs JBJ, Johnson AD (2015) The transcriptional landscape
of age in human peripheral blood. Nat. Commun. 6, 8570.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J,
Sklar P, de Bakker PIW, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-
genome association and population-based linkage analyses. Am. J. Hum. Genet.
81, 559–575.
Ravussin E, Redman LM, Rochon J, Das SK, Fontana L, Kraus WE, Romashkan S,
Williamson DA, Meydani SN, Villareal DT, Smith SR, Stein RI, Scott TM, Stewart
TM, Saltzman E, Klein S, Bhapkar M, Martin CK, Gilhooly CH, Holloszy JO,
Hadley EC, Roberts SB, CALERIE Study Group (2015) A 2-year randomized
controlled trial of human caloric restriction: feasibility and effects on predictors
of health span and longevity. J. Gerontol. A Biol. Sci. Med. Sci. 70, 1097–1104.
Rea JNM, Carvalho A, McNerlan SE, Alexander HD, Rea IM (2015) Genes and life-
style factors in BELFAST nonagenarians: nature, nurture and narrative.
Biogerontology 16, 587–597.
Rodwell GEJ, Sonu R, Zahn JM, Lund J, Wilhelmy J, Wang L, Xiao W, Mindrinos M,
Crane E, Segal E, Myers BD, Brooks JD, Davis RW, Higgins J, Owen AB, Kim SK
(2004) A transcriptional profile of aging in the human kidney. PLoS Biol. 2, e427.
Rozing MP, Houwing-Duistermaat JJ, Slagboom PE, Beekman M, Fr€olich M, De
Craen AJM, Westendorp RGJ, Van Heemst D (2010) Familial longevity is
associated with decreased thyroid function. J. Clin. Endocrinol. Metab. 95,
4979–4984.
Ruggiero C, Metter EJ, Melenovsky V, Cherubini A, Najjar SS, Ble A, Senin U, Longo
DL, Ferrucci L (2008) High basal metabolic rate is a risk factor for mortality: the
Baltimore Longitudinal Study of Aging. J. Gerontol. A Biol. Sci. Med. Sci. 63,
698–706.
Sch€achter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L,
Cohen D (1994) Genetic associations with human longevity at the APOE and
ACE loci. Nat. Genet. 6, 29–32.
Sebastiani P, Solovieff N, Dewan AT, Walsh KM, Puca A, Hartley SW, Melista E,
Andersen S, Dworkis DA, Wilk JB, Myers RH, Steinberg MH, Montano M,
Baldwin CT, Hoh J, Perls TT (2012) Genetic signatures of exceptional longevity in
humans. PLoS ONE 7, e29848.
Skytthe A, Christiansen L, Kyvik KO, Bødker FL, Hvidberg L, Petersen I, Nielsen
MMF, Bingley P, Hjelmborg J, Tan Q, Holm NV, Vaupel JW, McGue M,
Christensen K (2013) The Danish Twin Registry: linking surveys, national
registers, and biological information. Twin Res. Hum. Genet. 16, 104–111.
Soerensen M, Dato S, Christensen K, McGue M, Stevnsner T, Bohr VA,
Christiansen L (2010) Replication of an association of variation in the FOXO3A
gene with human longevity using both case-control and longitudinal data. Aging
Cell 9, 1010–1017.
Talens RP, Christensen K, Putter H, Willemsen G, Christiansen L, Kremer D,
Suchiman HED, Slagboom PE, Boomsma DI, Heijmans BT (2012) Epigenetic
Genomics of metabolic pathways in human longevity, R. H€asler et al.724
ª 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
variation during the adult lifespan: cross-sectional and longitudinal data on
monozygotic twin pairs. Aging Cell 11, 694–703.
Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with
RNA-Seq. Bioinformatics 25, 1105–1111.
Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg
SL, Wold BJ, Pachter L (2010) Transcript assembly and quantification by RNA-Seq
reveals unannotated transcripts and isoform switching during cell differentiation.
Nat. Biotechnol. 28, 511–515.
Van den Akker EB, Passtoors WM, Jansen R, van Zwet EW, Goeman JJ, Hulsman M,
Emilsson V, Perola M, Willemsen G, Penninx BWJH, Heijmans BT, Maier AB,
Boomsma DI, Kok JN, Slagboom PE, Reinders MJT, Beekman M (2014) Meta-
analysis on blood transcriptomic studies identifies consistently coexpressed
protein-protein interaction modules as robust markers of human aging. Aging
Cell 13, 216–225.
Von Wurmb-Schwark N, Schwark T, Caliebe A, Drenske C, Nikolaus S, Schreiber S,
Nebel A (2010) Low level of the mtDNA(4977) deletion in blood of exceptionally
old individuals. Mech. Ageing Dev. 131, 179–184.
Westra H-J, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J,
Christiansen MW, Fairfax BP, Schramm K, Powell JE, Zhernakova A,
Zhernakova DV, Veldink JH, Van den Berg LH, Karjalainen J, Withoff S,
Uitterlinden AG, Hofman A, Rivadeneira F, ‘t Hoen PAC, Reinmaa E, Fischer
K, Nelis M, Milani L, Melzer D, Ferrucci L, Singleton AB, Hernandez DG, Nalls
MA, Homuth G, Nauck M, Radke D, V€olker U, Perola M, Salomaa V, Brody J,
Suchy-Dicey A, Gharib SA, Enquobahrie DA, Lumley T, Montgomery GW,
Makino S, Prokisch H, Herder C, Roden M, Grallert H, Meitinger T, Strauch K,
Li Y, Jansen RC, Visscher PM, Knight JC, Psaty BM, Ripatti S, Teumer A,
Frayling TM, Metspalu A, van Meurs JBJ, Franke L (2013) Systematic
identification of trans eQTLs as putative drivers of known disease associations.
Nat. Genet. 45, 1238–1243.
Willcox BJ, Willcox DC (2014) Caloric restriction, caloric restriction mimetics, and
healthy aging in Okinawa: controversies and clinical implications. Curr. Opin.
Clin. Nutr. Metab. Care 17, 51–58.
Willcox BJ, Donlon TA, He Q, Chen R, Grove JS, Yano K, Masaki KH, Willcox DC,
Rodriguez B, Curb JD (2008) FOXO3A genotype is strongly associated with
human longevity. Proc. Natl. Acad. Sci. USA 105, 13987–13992.
Zhao S, Fung-Leung WP, Bittner A, Ngo K, Liu X (2014) Comparison of RNA-Seq
and microarray in transcriptome profiling of activated T cells. PLoS ONE 9,
e78644.
Supporting Information
Additional Supporting Information may be found online in the supporting
information tab for this article.
Fig. S1 Comparison of findings to previous transcriptomic studies.
Fig. S2 Unique and overlapping features compared to previous studies.
Fig. S3 Cross sectional mRNA regulation of three selected genes.
Fig. S4 mRNA expression of genes correlating with age.
Table S1 The top 25 up- and downregulated genes in LLI.
Table S2 All the significantly represented biological processes with respect to
the genes upregulated and downregulated in LLI (in the German samples).
Table S3 The top 50 cis-eQTLs associated with differentially expressed genes.
Table S4 The top 50 G9A interaction effects exhibited by differentially
expressed genes.
Table S5 The top 50 genes with heritable transcriptional activity; the best fit
model for these genes was AE (A=additive genetic effect, E=unique
environmental effect).
Table S6 List of 80 candidate genes and the TaqMan assays used for
validation.
Appendix S1 This file contains FPKM (fragments per kilobase of exon per
million fragments mapped) values for all German samples.
Appendix S2 This file contains FPKM (fragments per kilobase of exon per
million fragments mapped) values for all Danish samples.
Genomics of metabolic pathways in human longevity, R. H€asler et al. 725
ª 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
